Bellevue Life Sciences Acquisition Intangible Assets

Bellevue Life Sciences Acquisition (BLAC) currently reports a intangible assets of $140M as of March 2026. That compares with $150M in the prior-year period — down 4.9% year over year. Use the charts on this page to explore Bellevue Life Sciences Acquisition's intangible assets history and peer comparisons.

Bellevue Life Sciences Acquisition's intangible assets decreased from $150M to $140M — a 4.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellevue Life Sciences Acquisition reported $140M in intangible assets as of March 2026. That compares with $150M in the prior-year period — down 4.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bellevue Life Sciences Acquisition, and consider following BLAC for alerts when major investors trade the stock.